SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-235789
Filing Date
2022-09-01
Accepted
2022-09-01 08:55:56
Documents
18
Period of Report
2022-08-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d304797d8k.htm   iXBRL 8-K 52088
2 EX-2.1 d304797dex21.htm EX-2.1 475055
3 EX-99.1 d304797dex991.htm EX-99.1 96141
4 EX-99.2 d304797dex992.htm EX-99.2 41437
8 GRAPHIC g304797g0901165615428.jpg GRAPHIC 3742
9 GRAPHIC g304797g0901165615522.jpg GRAPHIC 2504
10 GRAPHIC g304797g0901165615678.jpg GRAPHIC 2330
  Complete submission text file 0001193125-22-235789.txt   960134

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA fmtx-20220831.xsd EX-101.SCH 2886
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE fmtx-20220831_lab.xml EX-101.LAB 17994
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fmtx-20220831_pre.xml EX-101.PRE 11281
12 EXTRACTED XBRL INSTANCE DOCUMENT d304797d8k_htm.xml XML 3367
Mailing Address 300 NORTH BEACON STREET SUITE 501 WATERTOWN MA 02472
Business Address 300 NORTH BEACON STREET SUITE 501 WATERTOWN MA 02472 617-679-1970
Forma Therapeutics Holdings, Inc. (Filer) CIK: 0001538927 (see all company filings)

IRS No.: 371657129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39333 | Film No.: 221219739
SIC: 2836 Biological Products, (No Diagnostic Substances)